about
Bioluminescence imaging reveals dynamics of beta cell loss in the non-obese diabetic (NOD) mouse modelIn vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetesAn overview of the necessary thymic contributions to tolerance in transplantation.Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.Accounting for chance in the calculus of autoimmune diseaseSmall intestinal intraepithelial TCRγδ+ T lymphocytes are present in the premature intestine but selectively reduced in surgical necrotizing enterocolitisEarly life establishment of site-specific microbial communities in the gutAn unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance.Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance.Dysregulation of T lymphocyte proliferative responses in autoimmunity.Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgeneThe "genomic storm" induced by bacterial endotoxin is calmed by a nuclear transport modifier that attenuates localized and systemic inflammationAn immunosufficient murine model for the study of human islets.Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity.Neonatal CD71+ Erythroid Cells Do Not Modify Murine Sepsis Mortality.Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.Regulation of B lymphocyte responses to Toll-like receptor ligand binding during diabetes prevention in non-obese diabetic (NOD) miceHematopoietic Stem Cell Mobilization Is Necessary but Not Sufficient for Tolerance in Islet Transplantation.Grave effects of a specific immune therapy.ERAD-icating mutant insulin promotes functional insulin secretion.A review of adolescent adherence in type 1 diabetes and the untapped potential of diabetes providers to improve outcomesLupus-Prone Mice Resist Immune Regulation and Transplant Tolerance Induction.Avenues for immunomodulation and graft protection by gene therapy in transplantation.Autoimmune alternating hypo- and hyperthyroidism in childrenRegulatory properties of the intestinal microbiome effecting the development and treatment of diabetesClinical assessment of HNF1A and GCK variants and identification of a novel mutation causing MODY2Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios.Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver.Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18.Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans.Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood.An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells.Clinical predictors of autoimmune and severe atopic disease in pediatric heart transplant recipients.Can technological solutions for diabetes replace islet cell function?Mechanisms of regulatory T cell counter-regulation by innate immunity.Host Expression of the CD8 Treg/NK Cell Restriction Element Qa-1 is Dispensable for Transplant ToleranceA direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantationBlockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival.Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site.GITR Blockade Facilitates Treg Mediated Allograft Survival.
P50
Q27312395-61D8E979-BE03-4FA5-87DD-5F11FDA47212Q28748969-21F8614A-DE42-455C-A028-19171FBCC930Q30275198-B85B8B8C-4F01-4F64-B826-B073EE7805A3Q30437086-70A3FAA5-03A9-42D2-AB2C-87EDB2653CD1Q33508323-7DB67E30-EF56-4F2D-BFA9-A452E56930E8Q33721659-50EB5A29-3343-4AED-8DEE-2CEA9A90B8D9Q33779231-27D33855-D208-46CB-B1FA-5603881E34EAQ34107735-2051B50E-D83A-41EB-A499-CF97D68FDB88Q34107796-C4357175-F27C-4246-B497-FEAC68968731Q34110530-2278DF4F-72E4-4D5E-B311-BCFCCE9BB8A6Q34267426-081EAA82-8232-440B-A14B-6B0A06449173Q34374054-2ABEA3D8-DA49-4663-82EE-DDA4F7B3E8FFQ34674640-561368D8-8317-413D-AE57-71CB626100EFQ35849275-7A1E65DA-4891-4115-81EA-E69A2E9EF1E6Q35864705-3365693C-568B-42DB-BE35-EC4FDD2DE27BQ36071375-9EF00BE4-C482-46ED-83B5-EA8ECC1F9D46Q36137667-EAE415D4-D546-47C6-A258-4125EE878254Q36178422-FDBA9F47-A3DC-4950-89EF-4207BDD431CAQ36208700-FAFF0427-5BDC-44F9-8603-E4FD17150437Q36253365-FD752AED-E309-4AF3-8AEE-B176B0E12289Q36407741-4B0808DD-3B4C-4B4D-9E34-6391647064C0Q36479452-B57732F9-84F5-4BCA-8F2E-2DBF2A20FB9BQ36505743-790027AC-137B-4B39-B581-616FE4FF660CQ36566374-82AB48D3-727F-4A4B-BDCE-1AE53E2670CBQ36576134-68BCB859-5920-4BAA-92D0-79CDBE32E0D0Q36576139-1648164B-01DA-48F0-ACB9-D65E4EF115F1Q36711904-A7480ACB-D9D0-4DF3-A6D5-2B4195346C36Q36824716-698A0788-A934-415E-AEB4-41B5F6E338F0Q36905009-8D0F9E59-3639-4EB5-A2F1-BCC120E4198BQ36989415-2388DF98-CF5A-4B6E-A0A4-100226B88949Q37354931-2B7EA19E-5EF0-418B-87A3-A46362D0837DQ37544947-36166E8E-1784-411F-9795-ADCA7F0BB5DEQ37705233-320EE938-3FDD-4C13-89B5-DF9E05D246E9Q37834905-CDBED3C8-0107-4C51-BA51-C57B0023D612Q38087790-6C148B9B-1373-4ABD-90CA-A5D19A7B4366Q41321623-E5EE33B3-1D70-40DC-9562-CA2A0DC0BC5FQ42105797-2D231871-D046-4B88-AC86-E408F73B98E0Q42429848-AAEC6127-A56A-4020-A863-503591A9A132Q42829392-1F0D4003-C49E-408E-AEA2-2888474458D8Q42941731-2E3D6765-0F27-4841-A3E1-DD00A1A953F8
P50
description
hulumtues
@sq
onderzoeker
@nl
pediatric researcher
@en
հետազոտող
@hy
name
Daniel J Moore
@ast
Daniel J Moore
@es
Daniel J Moore
@sl
Daniel J. Moore
@en
type
label
Daniel J Moore
@ast
Daniel J Moore
@es
Daniel J Moore
@sl
Daniel J. Moore
@en
altLabel
Daniel Moore
@en
prefLabel
Daniel J Moore
@ast
Daniel J Moore
@es
Daniel J Moore
@sl
Daniel J. Moore
@en
P106
P21
P31
P496
0000-0002-6889-9345